Sign in
4/A

Changes in Ownership

Kura Oncology, Inc. Filed Acc 0001209191-16-094981

Options or other derivatives

  • President and CEO acquired 125,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

WILSON TROY EDWARD · President and CEO

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2016-01-29 Grant or award : show line 1 in the form Option to purchase common stock +125,000 $4.80 2026-01-28 125,000 125,000 D
Loading xslF345X03/doc4a.xml…